The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.
To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.
For additional information please review our Privacy Policy.
1. Phase III study of cisplatin (P) plus etoposide (E) with concurrent chest radiation (XRT) followed by docetaxel (D) vs. observation in patients (pts) with stage III non-small cell lung cancer (NSCLC): An interim toxicity analysis of consolidation therapy.
Speaker pages are intended to connect and list abstracts, presentations and articles to authors of similar names, for your convenience. They are not intended to be a comprehensive list of authored work. ASCO sources currently utilized to create this list are meeting abstracts, virtual meeting presentations, and Educational Book articles. As additional sources are added the source list will be updated.
A speaker's name can be listed differently among various sources (i.e. J.P. Smith and John P. Smith). Authored work under a dissimilar name (nickname, abbreviations, or different spelling) will not be listed together.
